title: [Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications].
abstract: The liver plays a key-role in carbohydrates metabolism. Glucose intole-rance, overt diabetes mellitus and insulin resistance are characteristic features of patients with cirrhosis. Central hyperinsulinemia and peripheral insulin-resistance are the main explanations for the high prevalence of diabetes in patients with cirrhosis. On the other hand, type 2 diabetes is associated with a wide spectrum of liver diseases ranging from nonalcoholic fatty liver to cirrhosis and hepatocellular carcinoma. Carbohydrate metabolism abnormalities are a major aggravating risk factor in cirrhosis. Diabetes is also an independent negative prognostic factor in cirrhotic patients. This leads to specific diagnostic procedures and therapeutic issues. Patients with diabetes and liver disease frequently need insulin treatment. The presence of liver disease makes the treatment of diabetes complex, and additional research is needed to determine the best treatment strategies in these patients.
authors: Fédération d'Hépato-Gastroentérologie Médico-Chirurgicale, Hôpital Beaujon, Clichy.
authors: Sophie
authors: S
authors: Buyse
authors: Dominique
authors: D
authors: Valla
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000209:etiology; D048909:Diabetes Complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005234:Fatty Liver / Q000209:etiology; D018149:Glucose Intolerance / Q000209:etiology; D044882:Glucose Metabolism Disorders / Q000209:etiology* / Q000628:therapy; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology; D008099:Liver / Q000378:metabolism; D008103:Liver Cirrhosis / Q000150:complications* / Q000628:therapy; D008113:Liver Neoplasms / Q000209:etiology; D011379:Prognosis; D012307:Risk Factors